0001104659-22-065911.txt : 20220527
0001104659-22-065911.hdr.sgml : 20220527
20220527161735
ACCESSION NUMBER: 0001104659-22-065911
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220525
FILED AS OF DATE: 20220527
DATE AS OF CHANGE: 20220527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANTINI GINO
CENTRAL INDEX KEY: 0001276038
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 22977763
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 305 MADISON AVENUE
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 305 MADISON AVENUE
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
FORMER COMPANY:
FORMER CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20031113
4
1
tm2217184-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-05-25
0
0001270073
INTERCEPT PHARMACEUTICALS, INC.
ICPT
0001276038
SANTINI GINO
C/O INTERCEPT PHARMACEUTICALS, INC.
305 MADISON AVENUE
MORRISTOWN
NJ
07960
1
0
0
0
Common Stock
2022-05-25
4
A
0
7737
0
A
23645
D
Option to Purchase Common Stock
16.82
2022-05-25
4
A
0
12790
0
A
2032-05-25
Common Stock
12790
12790
D
Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2023 Annual Meeting of Stockholders.
All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2023 Annual Meeting of Stockholders.
/s/ Rocco Venezia, as attorney-in-fact
2022-05-27